Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cognitive Neuroscience,Neurology (clinical),Neurology
Reference17 articles.
1. Cholinesterase Inhibitors Used in the Treatment of Alzheimer???s Disease
2. Galantamine Prolonged-Release Formulation in the Treatment of Mild to Moderate Alzheimer’s Disease
3. Donepezil Is Associated with Delayed Nursing Home Placement in Patients with Alzheimer's Disease
4. Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease
5. Predictors of long-term cognitive outcome in Alzheimer's disease
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis;International Journal of Molecular Sciences;2021-08-27
2. Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations;Current Neuropharmacology;2021-06-23
3. Galanthamine and other Amaryllidaceae related alkaloids are inhibitors of α7, α4β2 and α3β4 nicotinic acetylcholine receptors;Revista Brasileira de Farmacognosia;2019-07
4. Framework of treating Alzheimer’s dementia;Brain Science Advances;2019-06
5. Galantamine plasma concentration and cognitive response in Alzheimer’s disease;PeerJ;2019-05-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3